Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 114
Filter
1.
Rev. venez. cir. ortop. traumatol ; 55(1): 38-45, jun. 2023. graf
Article in Spanish | LILACS, LIVECS | ID: biblio-1512030

ABSTRACT

El objetivo de este trabajo es determinar la epidemiología de la infección post osteosíntesis a través de cultivos de fluidos sonicados en los pacientes del Hospital Universitario de Caracas en el período comprendido entre noviembre 2021-noviembre 2022. Se realizó un estudio observacional de tipo, serie de casos, a través de la revisión de historias médicas de todos los casos que acudieron con diagnóstico de infección post osteosíntesis a fin de determinar cuál agente causal fue el más común, factores de riesgo asociados y tratamiento de elección. Se incluyeron 10 pacientes, 70% de sexo masculino y edad promedio de 40,6±17,9 años. Los gérmenes aislados en el cultivo convencional fueron el SAMS, SAMR, Enterobacter cloacae, Staphylococcus coagulasa negativo (10,0% cada uno), el 60,0% de los cultivos en esta modalidad fueron negativos, en el cultivo de fluidos por baño de ultrasonido, el germen más frecuente fue el SAMR en el 30% de los casos, seguido del SAMS con 20%, en menor medida un caso de Staphylococcus coagulasa negativo y una infección polimicrobiana compuesta por K. pneumoniae, E. cloacae y Enterococo sp. El tratamiento médico consistió en antibioticoterapia vía endovenosa, se realizó de acuerdo al antibiograma obtenido del cultivo, el más empleado fue la cefazolina en 30% (en casos de SAMS), seguido de la vancomicina + meropenem y la vancomicina aislada en 20%. Todos los pacientes cumplieron tratamiento al menos por 4 semanas con evolución satisfactoria(AU)


The objective of this work is to determine the epidemiology of post-osteosynthesis infection through sonicated fluid cultures in patients at the Hospital Universitario de Caracas in the period between November 2021 and November 2022. An observational study of type, series of cases, through the review of the medical records of all the cases that presented with a diagnosis of post-osteosynthesis infection in order to determine which causative agent was the most common, associated risk factors and treatment of choice. 10 patients were included, 70% male and mean age 40.6 ± 17.9 years. The germs isolated in the conventional culture were SAMS, SAMR, Enterobacter cloacae, coagulase-negative Staphylococcus (10.0% each), 60.0% of the cultures in this modality were negative, in the culture of fluids by bath of On ultrasound, the most frequent germ was MRSA in 30% of cases, followed by SAMS with 20%, to a lesser extent a case of coagulase-negative Staphylococcus and a polymicrobial infection made up of K. pneumoniae, E. cloacae and Enterococcus sp. The medical treatment consisted of intravenous antibiotic therapy, it was carried out according to the antibiogram obtained from the culture, the most used was cefazolin in 30% (in cases of SAMS), followed by vancomycin + meropenem and vancomycin alone in 20%. All patients complied with treatment for at least 4 weeks with satisfactory evolution(AU)


Subject(s)
Humans , Male , Female , Adolescent , Adult , Postoperative Care , Fracture Fixation, Internal , Infections/epidemiology , Enterobacter cloacae
2.
Rev. chil. infectol ; 39(3): 361-363, jun. 2022. tab
Article in Spanish | LILACS | ID: biblio-1407792

ABSTRACT

Resumen La aparición de Enterobacterales co-productores de dos o más carbapenemasas han despertado las alertas sanitarias en Latinoamérica. Las enterobacterias co-productoras de carbapenemasas KPC y NDM-1 son resistentes a casi todos los antibacterianos existentes. Panamá ha reportado la presencia de carbapenemasas KPC desde 2010 y NDM desde 2011; sin embargo, Enterobacterales con doble producción de carbapenemasas es un fenómeno reciente en nuestros hospitales. Presentamos los dos primeros aislados de Enterobacter cloacae complex co-productores de KPC y NDM, en un hospital de segundo nivel de la Ciudad de Panamá. El reforzamiento de los sistemas de vigilancia epidemiológica en los hospitales permite realizar una detección oportuna de estas nuevas combinaciones de mecanismos de resistencia; para así, implementar medidas de prevención y control de brotes.


Abstract Enterobacterales co-producing carbapenemases have awakened health alerts in Latin America. Carbapenemase-producing Enterobacterales harboring KPC and NDM-1 are resistant to almost all existing antibiotics. Panama reports KPC since 2010, and NDM since 2011, however, Enterobacterales with double carbapenemase production is new to our hospitals. We present the first two isolates of Enterobacter cloacae complex co-producing KPC and NDM, in a second level hospital in Panama City. Strengthening epidemiological surveillance systems in hospitals allows to carry out timely detection of these new combinations of resistance; to implement outbreak prevention and control measures.


Subject(s)
Humans , Male , Aged , Aged, 80 and over , Enterobacter cloacae/isolation & purification , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/epidemiology , Panama/epidemiology , Bacterial Proteins , beta-Lactamases , Hospitals , Latin America , Anti-Bacterial Agents/pharmacology
3.
Arch. argent. pediatr ; 119(2): e163-e166, abril 2021. ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-1152118

ABSTRACT

La endoftalmitis endógena neonatal es una patología poco frecuente que puede causar daño ocular grave. Puede manifestarse en pacientes con comorbilidades, como nacimiento pretérmino, bajo peso al nacer, complicaciones posquirúrgicas perinatales o sepsis.El presente reporte de caso documenta a una paciente pretérmino que fue sometida a múltiples cirugías abdominales. Durante su internación, desarrolló sepsis, meningitis y endoftalmitis endógena neonatal. La frecuencia extremadamente baja de la endoftalmitis endógena a esta edad, la importancia de preservar la salud visual del paciente y el abordaje interdisciplinario son puntos importantes de aprendizaje en este caso.


Neonatal endogenous endophthalmitis is a rare condition that can cause serious eye injuries. It can manifest in patients with comorbidities, such as preterm birth, low birth weight, post-surgical perinatal complications, or sepsis.This case report documents a preterm patient who underwent multiple abdominal surgeries. During her hospitalization, she developed sepsis, meningitis and neonatal endogenous endophthalmitis. The extremely low frequency of endogenous endophthalmitis at this age, the importance of preserving the patient's visual health, and the interdisciplinary approach are important learning points in this case.


Subject(s)
Humans , Female , Infant, Newborn , Endophthalmitis/diagnostic imaging , Postoperative Complications , Endophthalmitis/therapy , Enterobacter cloacae , Sepsis
4.
Salud pública Méx ; 62(1): 42-49, ene.-feb. 2020. tab, graf
Article in English | LILACS | ID: biblio-1366000

ABSTRACT

Abstract: Objective: To establish the current situation of antimicrobial resistance and antibiotic consumption in Mexican hospitals. Materials and methods: Antimicrobial susceptibility data from blood and urine isolates were collected. Defined daily dose (DDD) of antibiotic consumption/100 occupied beds (OBD) was calculated. Results: Study period: 2016 and 2017. Of 4 382 blood isolates, E. coli and K. pneumoniae were most frequently reported, with antimicrobial resistance >30% for most drugs tested, only for carbapenems and amikacin resistance were <20%. A. baumannii had antimicrobial resistance >20% to all drugs. Resistance to oxacillin in S. aureus was 20%. From 12 151 urine isolates, 90% corresponded to E. coli; resistance to ciprofloxacin, cephalosporins and trimethoprim/sulfamethoxazole was >50%, with good susceptibility to nitrofurantoin, amikacin and carbapenems. Global median antimicrobial consumption was 57.2 DDD/100 OB. Conclusions: This report shows a high antimicrobial resistance level in Gram-negative bacilli and provides an insight into the seriousness of the problem of antibiotic consumption.


Resumen: Objetivo: Establecer la situación actual de la resistencia antimicrobiana y el consumo de antibióticos en hospitales mexicanos. Material y métodos:F Se colectaron datos de susceptibilidad antimicrobiana de aislamientos de sangre y orina. Se calculó la dosis diaria definida (DDD) del consumo de antibióticos/100 estancias. Resultados: Periodo de estudio de 2016 a 2017. De 4 382 aislamientos en sangre, E. coli y K. pneumoniae fueron las más frecuentes, con resistencia >30% a la mayoría de las drogas evaluadas; sólo para carbapenémicos y amikacina la resistencia fue <20%. A. baumannii tuvo resistencia >20% a todos los fármacos. La resistencia a oxacilina en S. aureus fue de 20%. De 12 151 aislamientos en urocultivos, 90% correspondió a E. coli; la resistencia a ciprofloxacina, cefalosporinas y trimetoprima/sulfametoxazol fue >50%, con buena susceptibilidad a nitrofurantoína, amikacina y carbapenémicos. La mediana del consumo global de antibióticos en DDD/100 estancias fue de 57.2. Conclusiones: Este reporte muestra el nivel elevado de resistencia en bacilos Gram-negativos y brinda una perspectiva de la gravedad del problema del consumo de antibióticos.


Subject(s)
Humans , Drug Resistance, Bacterial , Hospitals/statistics & numerical data , Anti-Bacterial Agents/therapeutic use , Staphylococcus aureus/drug effects , Microbial Sensitivity Tests , Confidence Intervals , Retrospective Studies , Enterococcus faecium/drug effects , Enterobacter cloacae/drug effects , Acinetobacter baumannii/drug effects , Escherichia coli/drug effects , Hospitals/classification , Klebsiella pneumoniae/drug effects , Mexico
5.
Belo Horizonte; s.n; 2019. 89 p. graf, tab, ilus.
Thesis in Portuguese | BDENF, LILACS | ID: biblio-1010265

ABSTRACT

As cirurgias ortopédicas com uso de prótese são procedimentos utilizados para o tratamento de doenças em articulações. Embora seja um procedimento bastante utilizado, o paciente está sujeito as várias complicações e insucesso do tratamento. Entre essas complicações, a infecção de sítio cirúrgico (ISC) é uma das mais prevalentes, com incidências variando entre 1,4% e 12,6%. Para prevenir essa afecção, o acompanhamento da incidência e a monitorização de fatores de risco permitirão adoções de práticas de prevenção baseadas em evidências, visando uma assistência mais segura. Este estudo é uma coorte não concorrente de 149 pacientes submetidos à artroplastia total de quadril (ATQ) e artroplastia total de joelho (ATJ). O objetivo geral foi analisar os aspectos epidemiológicos das infecções de sitio cirúrgico nos pacientes submetidos à cirurgia ortopédica, no período de 2015 a 2018 em um hospital de grande porte de Belo Horizonte, Minas Gerais. Os objetivos específicos foram estimar a incidência das infecções de sítio cirúrgico; estimar a incidência de infecção de sítio cirúrgico (ISC) por topografia; identificar os fatores de risco associados à infecção ortopédica; identificar os microorganismos responsáveis pelas infecções e propor modelo preditivo multivariado. Na análise univariada, aplicou-se o teste não paramétrico de Mann Whitney. E para verificar a hipótese de associação entre as variáveis categóricas com os grupos, aplicouse o teste exato de Fisher. Na análise multivariada, aplicou-se o modelo de Regressão Logística (p-valor<0,05.) Foram notificadas seis ISC, com taxa global de 4,03%, todas caracterizadas como superficiais. Nos pacientes que foram submetidos à ATJ, a incidência de ISC foi de 2,94% e os que realizaram ATQ, 4,94%. Os fatores de risco identificados para ISC ortopédicas foram idade e hipertensão arterial sistêmica. Os microorganismos isolados foram Enterobacter cloacae, Acinetobacter baumannii e Stenotrophomonas maltophilia. As taxas de ISC encontradas neste estudo foram maiores que as recomendadas pelo NHSN/CDC.(AU)


Orthopedic surgeries with prosthesis are procedures used for the treatment of diseases in joints. Although it is a widely used procedure, the patient is subject to various complications and treatment failure. Among these complications, surgical site infection (SSI) is one of the most common, with incidence varying between 1.4% and 12.6%. To prevent this condition, monitoring incidence and monitoring risk factors will allow adoptions of evidencebased prevention practices for safer care. This study is a non-concurrent cohort of 149 patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA). The general objective was to analyze the epidemiological aspects of surgical site infections in patients submitted to orthopedic surgery from 2015 to 2018 at a large hospital in Belo Horizonte, Minas Gerais. The specific objectives were to estimate the incidence of surgical site infections; to estimate the incidence of surgical site infection (SSI) by topography; identify the risk factors associated with orthopedic infection; identify the microorganisms responsible for infections and propose a multivariate predictive model. In the univariate analysis, the nonparametric Mann Whitney test was applied. And to verify the hypothesis of association between the categorical variables with the groups, Fisher's exact test was applied. In the multivariate analysis, the Logistic Regression model was applied (p-value <0.05). Six SSIs were reported, with an overall rate of 4.03%, all characterized as superficial. In patients who underwent TKA, the incidence of SSI was 2.94% and those who undergoing TKA, 4.94%. The risk factors identified for orthopedic SSIs were age and systemic arterial hypertension. The isolated microorganisms were Enterobacter cloacae, Acinetobacter baumannii and Stenotrophomonas maltophilia. The SSI rates found in this study were higher than those recommended by the NHSN / CDC.(AU)


Subject(s)
Humans , Male , Female , Middle Aged , Surgical Wound Infection/epidemiology , Risk Factors , Arthroplasty, Replacement, Hip/adverse effects , Arthroplasty, Replacement, Knee/adverse effects , Prostheses and Implants/adverse effects , Surveys and Questionnaires , Retrospective Studies , Enterobacter cloacae , Academic Dissertation , Stenotrophomonas maltophilia , Acinetobacter baumannii
6.
Arch. argent. pediatr ; 116(6): 744-748, dic. 2018. ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-973689

ABSTRACT

La enfermedad granulomatosa crónica es una inmunodeficiencia primaria infrecuente, debida a un defecto en la actividad microbicida de los fagocitos, originada por mutaciones en los genes que codifican alguna de las subunidades del complejo enzimático nicotinamida adenina dinucleótido fosfato oxidasa. La incidencia estimada es 1 en 250 000 recién nacidos vivos. Puede presentarse desde la infancia hasta la adultez, por lo general, en menores de 2 años. Las infecciones bacterianas y fúngicas, en conjunto con las lesiones granulomatosas, son las manifestaciones más habituales de la enfermedad. Los microorganismos aislados más frecuentemente son Aspergillus spp., Staphylococcus aureus, Serratia marcescens, Nocardia spp. Se reporta el caso clínico de un varón de 1 año de vida en el que se diagnosticó enfermedad granulomatosa crónica a partir de infecciones múltiples que ocurrieron simultáneamente: aspergilosis pulmonar invasiva, osteomielitis por Serratia marcescens y granuloma cervical por Enterobacter cloacae.


Chronic granulomatous disease is an uncommon primary immunodeficiency due to a defect of the killing activity of phagocytes, caused by mutations in any of the genes encoding subunits of the superoxide-generating phagocyte NADPH oxidase system. The incidence is 1 in 250 000 live births. It can occur from infancy to adulthood, usually in children under 2 years. Bacterial and fungal infections in association with granuloma lesions are the most common manifestations of the disease. Aspergillus species, Staphylococcus aureus, Serratia marcescens, Nocardia species are the most common microorganisms isolated. We describe here a case of a 1-year-old boy with chronic granulomatous disease and invasive pulmonary aspergillosis, Serratia marcescens osteomyelitis and Enterobacter cloacae cervical granuloma.


Subject(s)
Humans , Male , Infant , Serratia Infections/diagnosis , Enterobacteriaceae Infections/diagnosis , Pulmonary Aspergillosis/diagnosis , Granulomatous Disease, Chronic/diagnosis , Osteomyelitis/diagnosis , Osteomyelitis/metabolism , Serratia marcescens/isolation & purification , Serratia Infections/microbiology , Enterobacter cloacae/isolation & purification , Enterobacteriaceae Infections/microbiology , Granulomatous Disease, Chronic/microbiology
7.
Rev. Soc. Bras. Med. Trop ; 51(5): 674-675, Sept.-Oct. 2018.
Article in English | LILACS | ID: biblio-1041482

ABSTRACT

Abstract INTRODUCTION: Enterobacter cloacae is a clinically important bacterium from the Enterobacteriaceae family. This study evaluated resistance of E. cloacae strains from fish (n=14) and shrimp (n=9) to colistin. METHODS: Biochemical identification and antimicrobial susceptibility tests were carried out in an automated Vitek®2 instrument. RESULTS: Colistin resistance was observed in 21.4% and 66.7% of the strains from fish and shrimp, respectively. We observed minimum inhibitory concentrations of ≥16 mg/L and ≤5 mg/L in 8 and 15 of all strains, respectively. CONCLUSIONS: Fish and shrimp can carry drug-resistant enterobacteria, which can be of clinical interest.


Subject(s)
Animals , Shellfish/microbiology , Enterobacter cloacae/drug effects , Seafood/microbiology , Colistin/pharmacology , Penaeidae/microbiology , Anti-Bacterial Agents/pharmacology , Microbial Sensitivity Tests , Drug Resistance, Bacterial
8.
Laboratory Medicine Online ; : 99-106, 2018.
Article in English | WPRIM | ID: wpr-715910

ABSTRACT

BACKGROUND: From January 2014 to December 2015, 69 clones of Enterobacter cloacae showing multidrug resistance to six classes of antimicrobial agents were collected from two medical centers in Korea. METHODS: Minimum inhibitory concentrations were determined using the E-test method, and 17 genes were detected using polymerase chain reaction (PCR). The epidemiological relatedness of the strains was identified using repetitive element sequence-based PCR and multilocus sequence typing. RESULTS: The 69 E. cloacae clones produced extended spectrum β lactamase (ESBL) and AmpC and showed multidrug resistance to cefotaxime, ceftazidime, and aztreonam. We identified the following sequence types: ST56 of type VI for ESBL SHV (N=12, 17.4%); ST53, ST114, ST113, and ST550 of types I, IV, VI, and VII, respectively, for CTX-M (N=11, 15.9%); and ST668 of type III for the carbapenemase NDM gene (N=1, 1.5%). The AmpC DHA gene (N=2, 2.89%) was confirmed as ST134, although its type was not identified, whereas EBC (MIR/ACT; N=18, 26.1%) was identified as ST53, ST24, ST41, ST114, ST442, ST446, ST484, and ST550 of types V, I, III, IV, VII, and VI, respectively. The formed subclasses were bla CTX-M-3 and bla CTX-M-22 by CTX-M-1, bla CTX-M-9 and bla CTX-M-125 by CTX-M-9, bla DHA-1 by DHA, and bla MIR-7 and bla ACT-15,17,18,25,27,28 by EBC (MIR/ACT). CONCLUSIONS: There were no epidemiological relationships between the gene products and the occurrence of resistance among the strains.


Subject(s)
Anti-Infective Agents , Aztreonam , Cefotaxime , Ceftazidime , Cloaca , Clone Cells , Drug Resistance, Multiple , Enterobacter cloacae , Enterobacter , Korea , Methods , Microbial Sensitivity Tests , Multilocus Sequence Typing , Polymerase Chain Reaction
9.
Annals of Laboratory Medicine ; : 555-562, 2018.
Article in English | WPRIM | ID: wpr-718327

ABSTRACT

BACKGROUND: The emerging mobile colistin resistance gene, mcr-1, is an ongoing worldwide concern and an evaluation of clinical isolates harboring this gene is required in Korea. We investigated mcr-1-possessing Enterobacteriaceae among Enterobacteriaceae strains isolated in Korea, and compared the genetic details of the plasmids with those in Escherichia coli isolates from livestock. METHODS: Among 9,396 Enterobacteriaceae clinical isolates collected between 2010 and 2015, 1,347 (14.3%) strains were resistant to colistin and those were screened for mcr-1 by PCR. Colistin minimum inhibitory concentrations (MICs) were determined by microdilution, and conjugal transfer of the mcr-1-harboring plasmids was assessed by direct mating. Whole genomes of three mcr-1-positive Enterobacteriaceae clinical isolates and 11 livestock-origin mcr-1-positive E. coli isolates were sequenced. RESULTS: Two E. coli and one Enterobacter aerogenes clinical isolates carried carried IncI2 plasmids harboring mcr-1, which conferred colistin resistance (E. coli MIC, 4 mg/L; E. aerogenes MIC, 32 mg/L). The strains possessed the complete conjugal machinery except for E. aerogenes harboring a truncated prepilin peptidase. The E. coli plasmid transferred more efficiently to E. coli than to Klebsiella pneumoniae or Enterobacter cloacae recipients. Among the three bacterial hosts, the colistin MIC was the highest for E. coli owing to the higher mcr-1-plasmid copy number and mcr-1 expression levels. Ten mcr-1-positive chicken-origin E. coli strains also possessed mcr-1-harboring IncI2 plasmids closely related to that in the clinical E. aerogenes isolate, and the remaining one porcine-origin E. coli possessed an mcr-1-harboring IncX4 plasmid. CONCLUSIONS: mcr-1-harboring IncI2 plasmids were identified in clinical Enterobacteriaceae isolates. These plasmids were closely associated with those in chicken-origin E. coli strains in Korea, supporting the concept of mcr-1 dissemination between humans and livestock.


Subject(s)
Humans , Colistin , Enterobacter aerogenes , Enterobacter cloacae , Enterobacteriaceae , Escherichia coli , Escherichia , Genome , Klebsiella pneumoniae , Korea , Livestock , Microbial Sensitivity Tests , Plasmids , Polymerase Chain Reaction
10.
Braz. j. microbiol ; 49(supl.1): 224-228, 2018. tab, graf
Article in English | LILACS | ID: biblio-1039272

ABSTRACT

ABSTRACT Enterobacter cloacae and E. aerogenes have been increasingly reported as important opportunistic pathogens. In this study, a high prevalence of multi-drug resistant isolates from Brazil, harboring several β-lactamase encoding genes was found. Several virulence genes were observed in E. aerogenes, contrasting with the E. cloacae isolates which presented none.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Bacterial Proteins/metabolism , beta-Lactamases/metabolism , Enterobacter cloacae/isolation & purification , Enterobacter aerogenes/isolation & purification , Virulence Factors/metabolism , Enterobacteriaceae Infections/microbiology , Phylogeny , Bacterial Proteins/genetics , Virulence , beta-Lactamases/genetics , Brazil , Microbial Sensitivity Tests , Enterobacter cloacae/classification , Enterobacter cloacae/enzymology , Enterobacter cloacae/genetics , Enterobacter aerogenes/classification , Enterobacter aerogenes/enzymology , Enterobacter aerogenes/genetics , Virulence Factors/genetics , Middle Aged , Anti-Bacterial Agents/pharmacology
11.
Journal of Laboratory Medicine and Quality Assurance ; : 155-160, 2018.
Article in English | WPRIM | ID: wpr-716936

ABSTRACT

BACKGROUND: This study was conducted to evaluate the impact of the media type used for direct identification of colonies on the surveillance culture of carbapenem-resistant Enterobacteriaceae (CRE) by matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). METHODS: CRE surveillance culture isolates were subjected to species identification using the MALDI Biotyper (Bruker Daltonics, Germany) for 2 months starting in March 2017. Four types of media were evaluated: blood agar (BA), Mueller Hinton agar (MH), MacConkey agar (Mac), and MacConkey agar containing imipenem of 1 µg/mL (IMP-Mac). CRE-like colonies on IMP-Mac and their subculture colonies on the other media were tested after overnight incubation and extended incubation for one additional day. The percent identification and score value were analyzed for each media types and incubation time when the identification was correct at the genus level. RESULTS: A total of 117 isolates were identified as 84 Klebsiella pneumoniae, 12 Escherichia coli, 9 Enterobacter cloacae, 5 Klebsiella oxytoca, 4 Enterobacter aerogenes, and 2 Raoultella ornithinolytica. The successful identification rates (SIR) for BA and MH were 98.3% and 97.4% (P=0.9), respectively, while those for Mac and IMP-Mac were 82.1% (P < 0.001) and 70.9% (P < 0.001), respectively. After extended incubation, SIRs were decreased to 96.6%, 96.6% (P=1.0), 61.5% (P < 0.001), and 58.1% (P < 0.001) on BA, MH, Mac, and IMP-Mac, respectively. The average score values were significantly lower for Mac (2.017±0.22) and IMP-Mac (1.978±0.24) than for BA (2.213±0.16) (P < 0.001). CONCLUSIONS: The low performance of the MALDI Biotyper applied directly to the colonies grown on Mac or IMP-Mac indicates that subculture on BA or MH is preferable before identification by MALDI-TOF MS.


Subject(s)
Agar , Enterobacter aerogenes , Enterobacter cloacae , Enterobacteriaceae , Escherichia coli , Imipenem , Klebsiella oxytoca , Klebsiella pneumoniae , Mass Spectrometry , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
12.
Rev. Soc. Bras. Med. Trop ; 50(5): 685-688, Sept.-Oct. 2017. tab
Article in English | LILACS | ID: biblio-1041426

ABSTRACT

Abstract INTRODUCTION: The rapid global spread of carbapenem-resistant Enterobacteriaceae (CRE) is a threat to the health system. METHODS: We evaluated the antimicrobial susceptibility profiles of 70 CRE isolated in a tertiary hospital in Brazil between August and December 2015, and determined their resistance mechanisms. RESULTS: The most prevalent microorganism was Klebsiella pneumoniae (95.7%); it showed high-level resistance to carbapenems (>98%), with sensitivity to colistin (91.4%) and amikacin (98.6%). The bla KPC gene was detected in 80% of the CRE isolates. CONCLUSIONS: Evaluation of bacterial resistance contributes to an appropriate treatment, and the reduction of morbimortality and dissemination of resistance.


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Adolescent , Adult , Young Adult , Enterobacteriaceae Infections/epidemiology , Tertiary Care Centers/statistics & numerical data , Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Brazil/epidemiology , Microbial Sensitivity Tests , Polymerase Chain Reaction , Cross Infection/epidemiology , Enterobacter cloacae/isolation & purification , Citrobacter freundii/isolation & purification , Enterobacteriaceae Infections/microbiology , Escherichia coli/isolation & purification , Genotype , Klebsiella pneumoniae/isolation & purification , Anti-Infective Agents/pharmacology , Middle Aged
13.
Ann. Univ. Mar. Ngouabi ; 17(1): 64-66, 2017.
Article in French | AIM | ID: biblio-1258837

ABSTRACT

Les Enterobacter sont des bacilles gram négatif anaérobies facultatifs. Ils ont été rarement rapportés dans la méningite communautaire. L'enfant L.R, de sexe masculin, âgé de 6ans est admis en SIP pour une convulsion. Il a présenté 6 jours auparavant une fièvre permanente à 40°C, des céphalées en casque et des vomissements spontanés. Il est drépanocytaire homozygote connu depuis l'âge de 11 mois au décours d'une crise anémique, il n'est pas suivi, et a été deux transfusé (2014 et 2015). L'examen clinique retrouvait : un enfant comateux (Glasgow à10/15) ; des signes d'irritation méningée (raideur invincible de la nuque, Kernig et Brudzinski), une pâleur avec ictère modéré ; un état hémodynamique stable (TA 90/60mmHg, TRC<3s).Le bilan paraclinique montrait : Un liquide cérébro-spinal (LCS) trouble avec plus de 1000 dont 99% étaient des polynucléaires altérés, une hyperproteinorachie à 3g, une hypoglycorachie à 0,03g/l ; l'examen bactériologique du LCS avait permis l'identification des nombreux bacilles à Gram négatif. L'hémoculture a isolé un Enterobacter spp résistant à la céfixime, céftriaxone, amikacine, gentamycine. L'évolution était favorable sous ciprofloxacine. Cette observation suggère qu'une étude soit réalisée pour établir l'écologie bactérienne actuelle de la méningite de l'enfant à Brazzaville


Subject(s)
Enterobacter cloacae
14.
Asian Spine Journal ; : 427-436, 2017.
Article in English | WPRIM | ID: wpr-197439

ABSTRACT

STUDY DESIGN: A retrospective clinical review. PURPOSE: To investigate the difference in clinical manifestations and severity between polymicrobial and monomicrobial infections after spinal surgery. OVERVIEW OF LITERATURE: Surgical site infections (SSIs) after spinal surgery are a major diagnostic and therapeutic challenge for spinal surgeons. Polymicrobial infections after spinal surgery seem to result in poorer outcomes than monomicrobial infections because of complementary resistance to antibiotics. However, comparison of the clinical manifestations and severity between polymicrobial and monomicrobial infections are limited. METHODS: Sixty-seven patients with SSIs after spinal surgery were studied: 20 patients with polymicrobial infections and 47 with monomicrobial infections. Pathogenic bacteria identified were counted and classified. Age, sex, and body mass index were compared between the two groups to identify homogeneity. The groups were compared for clinical manifestations by surgical site, postoperative time to infection, infection site, incisional drainage, incisional swelling, incisional pain, neurological signs, temperature, white blood cell count, and the percentage of neutrophils. Finally, the groups were compared for severity by hospital stay, number of rehospitalizations, number of debridements, duration of antibiotics administration, number of antibiotics administered, and implant removal. RESULTS: Polymicrobial infections comprised 29.9% of SSIs after spinal surgery, and most polymicrobial infections (70.0%) were caused by two species of bacteria only. There was no difference between the groups in terms of clinical manifestations and severity. In total, 96 bacterial strains were isolated from the spinal wounds: 60 strains were gram-positive and 36 were gram-negative pathogenic bacteria. Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, and Enterobacter cloacae were cultured in order of the frequency of appearance. CONCLUSIONS: Most polymicrobial infections were caused by two bacterial species after spinal surgery. There was no difference in clinical manifestations or severity between polymicrobial and monomicrobial infections.


Subject(s)
Humans , Anti-Bacterial Agents , Bacteria , Body Mass Index , Coinfection , Debridement , Drainage , Enterobacter cloacae , Escherichia coli , Length of Stay , Leukocyte Count , Neutrophils , Postoperative Complications , Retrospective Studies , Spine , Staphylococcus aureus , Staphylococcus epidermidis , Surgeons , Surgical Wound Infection , Wounds and Injuries
15.
Bol. latinoam. Caribe plantas med. aromát ; 15(4): 199-205, jul. 2016. tab
Article in English | LILACS | ID: biblio-907537

ABSTRACT

Aloysia polystachya and Lippia turbinata are medicinal and aromatic plants. Nevertheless, there are few reports in literature concerning the biological properties of species that grow in northeastern Argentina. The antibacterial activity and the chemical composition of both essential oils were evaluated in this work. The extraction was performed by steam distillation and their volatile compounds were determined by gas chromatography/mass spectrometry. The antibacterial activity was evaluated by disc diffusion and broth microdilution assay. The main compounds were carvone (78.9 percent) and limonene (14.2 percent) in A. polystachya and carvone (80.77 percent), limonene (8.73 percent), beta- caryophyllene (2.13 percent) and 1,8-cineole (1.70 percent) in L. turbinata. Both essential oils were bactericide against Escherichia coli ATCC 35218 and clinical isolates of Enterobacter cloacae and Klebsiella pneumoniae. Essential oil of A. polystachya was also bactericide against Staphylococcus aureus ATCC 29212, S. aureus ATCC 25923 and clinical strain of S. aureus methicillin susceptible.


Aloysia polystachya y Lippia turbinata son plantas medicinales y aromáticas. Hay pocos informes en la literatura sobre las propiedades biológicas de especies que crecen en el nordeste de Argentina. La actividad antibacteriana y la composición química de ambas especies se evaluaron en este trabajo. La extracción se realizó por destilación con vapor y sus compuestos se determinaron por cromatografía gaseosa/espectrometría de masa. La actividad antibacteriana fue evaluada por difusión en discos y microdilución en caldo. Los principales compuestos fueron carvona (78.9 por ciento) y limoneno (14.2 por ciento) en A. polystachya y carvona (80.77 por ciento), limoneno (8.73 por ciento), beta-cariofileno (2.13 por ciento) y 1,8-cineol (1.70 por ciento) en L. turbinata. Ambos aceites esenciales fueron activos contra Escherichia coli ATCC 35218 y aislamientos clínicos de Enterobacter cloacae y Klebsiella pneumoniae. El aceite esencial de A. polystachya fue bactericida contra Staphylococcus aureus ATCC 29212, S. aureus ATCC 25923 y aislamientos clínicos de S. aureus sensible a meticilina.


Subject(s)
Anti-Bacterial Agents/pharmacology , Oils, Volatile/chemistry , Oils, Volatile/pharmacology , Plant Extracts/pharmacology , Verbenaceae/chemistry , Anti-Bacterial Agents/chemistry , Enterobacter cloacae , Escherichia coli , Staphylococcus aureus , Terpenes/analysis
16.
Rev. Soc. Bras. Med. Trop ; 49(3): 286-291, tab
Article in English | LILACS | ID: lil-785795

ABSTRACT

Abstract: INTRODUCTION: Plasmid-mediated quinolone resistance (PMQR) is a growing clinical concern worldwide. The main aims of this study were to detect qnr-encoding genes and to evaluate the clonal relatedness of qnr-positive Enterobacter cloacae isolates. METHODS: A total of 116 E. cloacae isolates that were not susceptible to quinolone were obtained from seven hospitals in Tehran, five hospitals in Qazvin, and two hospitals in Karaj (Iran). Bacterial identification was performed using standard laboratory methods and API 20E strips. Quinolone resistance was determined using the Kirby-Bauer disk diffusion method according to the Clinical Laboratory Standards Institute (CLSI) guidelines. PCR and sequencing were employed to detect qnrA, qnrB, and qnrS genes, and clonal relatedness was assessed using the enterobacterial repetitive intergenic consensus (ERIC)-PCR method. RESULTS: In total, 45 (38.8%) and 71 (61.2%) of isolates showed high- and low-level quinolone resistance, respectively, and qnr-encoding genes were detected in 70 (60.3%) of them. qnrB1 [45 (38.8%) isolates] was the most commonly detected gene, followed by qnrS1 [28 (24.1%) isolates] and qnrB4 [18 (15.5%) isolates] either alone or in combination with other genes. The results of the ERIC-PCR revealed that 53 (75.7%) qnr-positive isolates were genetically unrelated. CONCLUSIONS: This study describes, for the first time, the high prevalence of the qnrB1, qnrS1, and qnrB4 genes among E. cloacae isolates in Iran. The detection of qnr genes emphasizes the need for establishing tactful policies associated with infection control measures in hospital settings in Iran.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Aged , Aged, 80 and over , Young Adult , Enterobacter cloacae/drug effects , Quinolones/pharmacology , Drug Resistance, Bacterial , Enterobacteriaceae Infections/microbiology , Anti-Bacterial Agents/pharmacology , Plasmids/genetics , Microbial Sensitivity Tests , Prevalence , Cross-Sectional Studies , Enterobacter cloacae/genetics , Iran , Middle Aged
17.
Infection and Chemotherapy ; : 160-165, 2016.
Article in English | WPRIM | ID: wpr-28875

ABSTRACT

BACKGROUND: Extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) are increasingly reported as pathogens in urinary tract infections (UTIs). However, in Sri Lanka, the clinical and molecular epidemiology of ESBL-PE implicated in UTIs has not been well described. MATERIALS AND METHODS: We conducted prospective, laboratory-based surveillance from October to December 2013 at a tertiary care hospital in southern Sri Lanka and enrolled patients ≥1 year of age with clinically relevant UTIs due to ESBL-PE. Isolate identity, antimicrobial drug susceptibility, and ESBL production were determined. Presence of ß-lactamase genes, bla(SHV), bla(TEM), and bla(CTX-M), was identified by polymerase chain reaction. RESULTS: During the study period, Enterobacteriaceae were detected in 184 urine samples, with 74 (40.2%) being ESBL producers. Among 47 patients with ESBL-PE who had medical records available, 38 (80.9%) had clinically significant UTIs. Most UTIs (63.2%) were community acquired and 34.2% were in patients with diabetes. Among 36 cultured ESBL-PE isolates, significant susceptibility (>80%) was only retained to amikacin and the carbapenems. The group 1 bla(CTX-M) gene was present in 90.0% of Escherichia coli isolates and all Klebsiella pneumoniae and Enterobacter cloacae isolates. The bla(SHV) and bla(TEM) genes were more common in K. pneumoniae (75% and 50%) and E. cloacae (50% and 50%) isolates than in E. coli (10% and 20%) isolates, respectively. CONCLUSION: The majority of UTIs caused by ESBL-PE were acquired in the community and due to organisms carrying the group 1 CTX-M ß-lactamase. Further epidemiologic studies of infections due to ESBL-PE are urgently needed to better prevent and treat these infections in South Asia.


Subject(s)
Humans , Amikacin , Asia , Carbapenems , Cloaca , Enterobacter cloacae , Enterobacteriaceae , Epidemiologic Studies , Escherichia coli , Klebsiella pneumoniae , Medical Records , Molecular Epidemiology , Pneumonia , Polymerase Chain Reaction , Prospective Studies , Sri Lanka , Tertiary Healthcare , Urinary Tract Infections , Urinary Tract
18.
Infection and Chemotherapy ; : 166-173, 2016.
Article in English | WPRIM | ID: wpr-28874

ABSTRACT

BACKGROUND: Carbapenemase-producing Enterobacteriaceae (CPE) are Gram-negative bacteria with increasing prevalence of infection worldwide. In Korea, 25 cases of CPE isolates were reported by the Korea Centers for Disease Control and Prevention in 2011. Most CPE cases were detected mainly at tertiary referral hospitals. We analyzed the prevalence and risk factors for carbapenem-resistant Enterobacteriaceae (CRE) in a mid-sized community-based hospital in Korea. MATERIALS AND METHODS: We retrospectively analyzed all consecutive episodes of Enterobacteriaceae in a mid-sized community-based hospital from January 2013 to February 2014. CRE was defined as organisms of Enterobacteriaceae showing decreased susceptibility to carbapenems. Risk factors for CRE were evaluated by a case–double control design. Carbapenemase was confirmed for CRE using a combined disc test. RESULTS: During 229,710 patient-days, 2,510 Enterobacteriaceae isolates were obtained. A total of 41 (1.6%) CRE isolates were enrolled in the study period. Thirteen species (31.7%) were Enterobacter aerogenes, 8 (19.5%) Klebsiella pneumoniae, 5 (12.2%) Enterobacter cloacae, and 15 other species of Enterobacteriaceae, respectively. Among the 41 isolates, only one (2.4%) E. aerogenes isolate belonged to CPE. For evaluation of risk factors, a total of 111 patients were enrolled and this included 37 patients in the CRE group, 37 in control group I (identical species), and 37 in control group II (different species). Based on multivariate analysis, regularly visiting the outpatient clinic was a risk factor for CRE acquisition in the control group I (P = 0.003), while vascular catheter and Charlson comorbidity index score ≥ 3 were risk factors in control group II (P = 0.010 and 0.011, each). Patients with CRE were more likely to experience a reduced level of consciousness, use a vasopressor, be under intensive care, and suffer from acute kidney injury. However, CRE was not an independent predictor of mortality compared with both control groups. CONCLUSION: In conclusion, the prevalence of CRE was higher than expected in a mid-sized community-based hospital in Korea. CRE should be considered when patients have a vascular catheter, high comorbidity score, and regular visits to the outpatient clinic. This study suggests the need for appropriate prevention efforts and constant attention to CRE infection control in a mid-sized community-based hospital.


Subject(s)
Humans , Acute Kidney Injury , Ambulatory Care Facilities , Carbapenems , Comorbidity , Consciousness , Critical Care , Drug Resistance , Enterobacter aerogenes , Enterobacter cloacae , Enterobacteriaceae , Gram-Negative Bacteria , Infection Control , Klebsiella pneumoniae , Korea , Mortality , Multivariate Analysis , Prevalence , Retrospective Studies , Risk Factors , Tertiary Care Centers , Vascular Access Devices
19.
Annals of Clinical Microbiology ; : 59-64, 2016.
Article in Korean | WPRIM | ID: wpr-158515

ABSTRACT

BACKGROUND: Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae are resistant to most β-lactam antibiotics except carbapenems. In recent years, infrequently isolated Enterobacteriaceae that produce carbapenemase pose a serious threat in the selection of appropriate therapeutic antibiotics. The rapid detection method of carbapenemase-producing Enterobacteriaceae (CPE) is necessary to prevent the spread of CPE into healthcare facilities. METHODS: One hundred clinical Enterobacteriaceae isolates (Klebsiella pneumoniae 40, Escherichia coli 40, others 20) showing susceptibility to carbapenems and positivity in the CLSI ESBL phenotypic test from November 2015 to March 2016 and 59 stocked Enterobacteriaceae isolates harboring resistance genes producing carbapenemase (K. pneumoniae 56, Enterobacter cloacae 2, E. coli 1; types of CPE: KPC 36, GES 12, NDM 6, VIM 2, OXA 2, IMP 1) were subjected to the RAPIDEC CARBA NP test (bioMérieux, France) and CPE phenotypic test using the modified Hodge test (MHT) and carbapenemase inhibition test. RESULTS: All of the 100 Enterobacteriaceae isolates with carbapenem susceptibility and ESBL positivity were negative on the RAPIDEC CARBA NP test and CPE phenotypic test. Of 59 stock CPE isolates, 53 and 42 showed positive results to the RAPIDEC CARBA NP test and MHT, respectively. The sensitivity and specificity of the RAPIDEC CARBA NP test for detecting CPE were 89.8% and 100%, respectively. CONCLUSION: The RAPIDEC CARBA NP test is simple and produces a result within 3 hr. In conclusion, the test is a useful screen for detecting CPE because it shows high sensitivity and specificity for CPE detection.


Subject(s)
Anti-Bacterial Agents , Carbapenems , Delivery of Health Care , Enterobacter cloacae , Enterobacteriaceae , Escherichia coli , Methods , Pneumonia , Sensitivity and Specificity
20.
Invest. clín ; 56(2): 182-187, jun. 2015. ilus, graf
Article in Spanish | LILACS | ID: biblio-841077

ABSTRACT

An 83-year-old male patient is admitted to the central hospital in Cumaná, Venezuela with severe urinary infection, history of hospitalizations and prolonged antimicrobial treatments. A strain of Enterobacter cloacae was isolated showing resistance to multiple types of antibiotics (only sensitive to gentamicin), with phenotype of serine- and metallo-carbapenemases. Both, blaVIM-2 and blaKPC genes were detected in the isolate. This is the first report of an Enterobacteriaceae species producing both KPC carbapenemase and VIM metallo carbapenemase in Venezuela. This finding has a great clinical and epidemiological impact in the region, because of the feasibility of transferring these genes, through mobile elements to other strains of Enterobacter and to other infection-causing species of bacteria.


En un paciente masculino de 83 años, que ingresó al Hospital de Cumaná, Venezuela, con diagnóstico de infección urinaria severa, antecedentes de hospitalización y diferentes tratamientos antimicrobianos durante largos periodos de tiempo, se aisló una cepa de Enterobacter cloacae, la cual evidenció resistencia a múltiples tipos de antibióticos (solo sensible a gentamicina) y con fenotipo de carbapenemasas de tipo serina y metalobetalactamasa. Los genes blaVIM-2 y blaKPC fueron detectados en esta cepa. Este representa el primer reporte de una especie de Enterobacteriaceae productora simultánea de carbapenemasa KPC y metalobetalactamasa VIM en Venezuela. Esto tiene un gran impacto clínico y epidemiológico en la región por la posibilidad de transferencia de estos genes a otras cepas de Enterobacter u otras especies bacterianas causantes de infecciones, por medio de elementos móviles.


Subject(s)
Aged, 80 and over , Humans , Male , beta-Lactamases/genetics , Enterobacter cloacae/isolation & purification , Enterobacteriaceae Infections/genetics , Urinary Tract Infections/microbiology , Urinary Tract Infections/drug therapy , Venezuela , Enterobacter cloacae/genetics , Drug Resistance, Multiple, Bacterial , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/drug therapy , Anti-Bacterial Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL